Biotech company hopes to make Louisville a hub for cell therapy
The former Talaris space on the U of L Health Sciences Campus downtown won't be quiet for long.
Stay updated with breaking news from Suzanne Ildstad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The former Talaris space on the U of L Health Sciences Campus downtown won't be quiet for long.
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily volume of 629,200 shares, […]
The announcement follows Talaris Therapeutics’ unsuccessful effort to commercialize a stem cell therapy that promised to improve transplant recipients’ tolerance of new organs.
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 16,870 shares of the company’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $2.59, for a total value of $43,693.30. Following the transaction, the director now directly owns 3,798,542 shares of the company’s stock, valued […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 12,942 shares of Talaris Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $2.49, for a total value of $32,225.58. Following the completion of the transaction, the director now directly owns 3,771,392 shares in the […]